Prevention of coronary heart diseases and lipid-lowering therapy in Japan

被引：0
|
作者：
Saito, Y [1 ]
机构：
[1] Chiba Univ, Dept Internal Med 2, Chuo Ku, Chiba 2600856, Japan
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2000年 / 2卷 / 0D期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：D49 / D50
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering therapy for the primary prevention of coronary heart disease
    Gotto, AM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) : 2078 - 2082
  • [2] Trials of lipid-lowering therapy in primary prevention of coronary heart disease
    Jones, PH
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 365 - 368
  • [3] Trials of lipid-lowering therapy in secondary prevention of coronary heart disease
    Olsson, AG
    Pedersen, T
    Bergdahl, B
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 369 - 373
  • [4] Lipid-lowering drugs and prevention of coronary heart disease.
    Chadarevian, R
    Bruckert, E
    Turpin, G
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (02): : 89 - 98
  • [5] Lipid-lowering strategies for the prevention of coronary heart disease: Reply
    Haq, IU
    Ramsay, LE
    Pickin, DM
    Yeo, WW
    Jackson, PR
    Payne, JN
    CLINICAL SCIENCE, 1997, 92 (04) : 431 - 432
  • [6] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
  • [7] Comparison of current guidelines for primary prevention of coronary heart diseaseRisk assessment and lipid-lowering therapy
    Uli C. Broedl
    Hans-Christian Geiss
    Klaus G. Parhofer
    Journal of General Internal Medicine, 2003, 18 : 190 - 195
  • [8] Lipid-lowering for prevention of coronary heart disease: What policy now?
    UlHaq, I
    Ramsay, LE
    Pickin, DM
    Yeo, WW
    Jackson, PR
    Payne, JN
    CLINICAL SCIENCE, 1996, 91 (04) : 399 - 413
  • [9] Pharmacogenetics of apolipoprtein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
    Nieminen, Tuomo
    Kahonen, Mika
    Viiri, Leena E.
    Gronroos, Paula
    Lehtimaki, Terho
    PHARMACOGENOMICS, 2008, 9 (10) : 1475 - 1486
  • [10] Comparison of current guidelines for primary prevention of coronary heart disease - Risk assessment and lipid-lowering therapy
    Broedl, UC
    Geiss, HC
    Parhofer, KG
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (03) : 190 - 195
12345